Mark G. Ward

Recombinant human leukemia inhibitory factor induces acute phase proteins and raises the blood platelet counts in nonhuman primates

P. Mayer, Mark G. Ward, D Metcalf · Blood · 1993 · 63 citations · Full text

Medicine, Hematology, Pharmacology +7

Prevalence and Risk Factors for Functional Vitamin B12 Deficiency in Patients with Crohnʼs Disease

Mark G. Ward, Viraj C. Kariyawasam, Sathis B. Mogan et al. · Inflammatory Bowel Diseases · 2015 · 63 citations · Full text

Public Health, Nutrition, Nutritional Sciences +15

Infliximab and adalimumab drug levels in Crohn's disease: contrasting associations with disease activity and influencing factors

Mark G. Ward, Ben Warner, N Unsworth et al. · Alimentary Pharmacology & Therapeutics · 2017 · 62 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Infliximab, adalimumab and vedolizumab concentrations across pregnancy and vedolizumab concentrations in infants following intrauterine exposure

Emma Flanagan, Peter R. Gibson, Emily K. Wright et al. · Alimentary Pharmacology & Therapeutics · 2020 · 54 citations

Medicine, Pharmacokinetics, Pharmacology +14

Intra‐patient variability in adalimumab drug levels within and between cycles in Crohn's disease

Mark G. Ward, Phoebe A. Thwaites, Lauren Beswick et al. · Alimentary Pharmacology & Therapeutics · 2017 · 43 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15